NEMA NU 4-Optimized Reconstructions for Therapy Assessment in Cancer Research with the Inveon Small Animal PET/CT System

Mol Imaging Biol. 2015 Jun;17(3):403-12. doi: 10.1007/s11307-014-0805-5.

Abstract

Purpose: We compared conventional filtered back-projection (FBP), two-dimensional-ordered subsets expectation maximization (OSEM) and maximum a posteriori (MAP) NEMA NU 4-optimized reconstructions for therapy assessment.

Procedures: Varying reconstruction settings were used to determine the parameters for optimal image quality with two NEMA NU 4 phantom acquisitions. Subsequently, data from two experiments in which nude rats bearing subcutaneous tumors had received a dual PI3K/mTOR inhibitor were reconstructed with the NEMA NU 4-optimized parameters. Mann-Whitney tests were used to compare mean standardized uptake value (SUV(mean)) variations among groups.

Results: All NEMA NU 4-optimized reconstructions showed the same 2-deoxy-2-[(18)F]fluoro-D-glucose ([(18)F]FDG) kinetic patterns and detected a significant difference in SUV(mean) relative to day 0 between controls and treated groups for all time points with comparable p values.

Conclusion: In the framework of therapy assessment in rats bearing subcutaneous tumors, all algorithms available on the Inveon system performed equally.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Algorithms
  • Animals
  • Enzyme Inhibitors / chemistry
  • Female
  • Image Processing, Computer-Assisted*
  • Multimodal Imaging
  • Ovarian Neoplasms / diagnostic imaging
  • Ovarian Neoplasms / drug therapy
  • Phantoms, Imaging
  • Phosphoinositide-3 Kinase Inhibitors
  • Positron-Emission Tomography*
  • Radiopharmaceuticals / chemistry
  • Rats
  • Rats, Nude
  • Scattering, Radiation
  • Tomography, X-Ray Computed*

Substances

  • Enzyme Inhibitors
  • Phosphoinositide-3 Kinase Inhibitors
  • Radiopharmaceuticals